February 3rd, 2012 | Austin, Texas

Texans for Stem Cell Research (TSCR)  kicks off  the their 2012 ” Learn for Life” educational series at the Hyatt Regency, Austin.  TSCR and community partners will welcome Dr. Sean Savtiz, a member of their Medical Advisory Committee, and one of the leading doctors currently conducting stem cell clinical trials for victims of a stroke.

Sean I. Savitz, MD, FAHA       
Associate Professor, Department of Neurology
Director, Vascular Neurology Fellowship Program
Director, Cellular Therapy and Translational Stroke Research
Co-Director, Vascular Neurology Stroke Program
University of Texas Medical School at Houston
Houston, Texas

Cellular therapy, including the use of stem cells, is a promising new investigational approach for the treatment of stroke. Extensive animal studies have shown that various stem cells and other types of cells enhance recovery from stroke. Dr. Sean Savitz and the team at the University of Texas Medical School at Houston are investigating the safety and efficacy of cell therapies for stroke both in animal research and in clinical trials.

The UT System Board of Regents and the Texas State Legislature established one of the leading clinical and research organizations in the world, the University of Texas Health Science Center at Houston in 1972.  They have been conducting stem cell studies to include the use of autologous adult stem cells for the treatment of children with acute brain injuries. Sean Savitz, M.D, Director of Cellular Therapy and Translational Stroke Research and Co-Director of the Vascular Neurology Stroke Program leads a first-of-its-kind, FDA-approved, NIH funded, Phase I bone marrow stem cell therapy clinical trial for patients showing initial stroke symptoms. As part of the trial, the first patient in the US received intravenous injection of his own bone marrow stem cells.

Please Visit Official TSCR Website for Details

Read Press Release

Watch Presentation